Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-050043

Chief Scientific Officer sold 3,000 shares at an average $83.07 ($249,215)

  • Chief Scientific Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Biller Scott Chief Scientific Officer 2018-09-05 Option exercise +3,000 $9.05 $27,150 60,196 D
Biller Scott Chief Scientific Officer 2018-09-05 Sale −640 $82.52 $52,813 59,556 D
Biller Scott Chief Scientific Officer 2018-09-05 Sale −2,260 $83.17 $187,964 57,296 D
Biller Scott Chief Scientific Officer 2018-09-05 Sale −100 $84.38 $8,438 57,196 D
Derivatives
Biller Scott Chief Scientific Officer 2018-09-05 Option exercise · Stock options (right to buy) −3,000 10,154 D
Open-market sales · 3,000 sh · avg $83.07 · $249,215
Loading xslF345X03/doc4.xml…